MSH2 and non-small cell lung carcinoma: In an analysis of NSCLC (non-small cell lung carcinoma) patients, Hsu et al. 40 showed that hypermethylation of the promoter regions of the hMSH2 and hMLH1 genes was associated with poor patient survival.